发布: 2018年11月20日第8卷第22期 DOI: 10.21769/BioProtoc.3082 浏览次数: 8625
评审: Alka MehraKathrin SutterAnonymous reviewer(s)
Abstract
Cytotoxic CD8+ T lymphocytes (CTLs) represent a crucial component of the adaptive immune system and play a prominent role in the anti-tumor immune responses of both mice and humans.
Cytotoxic CD8+ T cells are responsible for the lysis of cells expressing peptides associated with MHC class I molecules and derived from infection with a pathogen or from mutated antigens. In order to quantify in vivo this antigen-specific CD8+ T cell killing activity, we use the in vivo killing assay (IVKA). Here, we describe the protocol for the lysis of cells expressing a CD8+ T cell melanoma epitope of the hgp10025-33 protein (KVPRNQDWL). C57BL/6 recipient mice, receive first target cells, prepared from naive congenic (CD45.1) C57BL/6 spleen cells pulsed with the hgp10025-33 peptide and labeled with CFSE and of non-pulsed control cells labeled with Brilliant violet. One day later, the spleen cells of recipient mice are isolated and analyzed by FACS to measure the amount of CFSE cells and Brillant Violet (BV) cells. The percentage of lysis is calculated by the difference between CFSE versus BV.
Measuring the ability of antigen-specific CD8+ T cells to lyse their antigen in vivo is very important to evaluate the adaptive cytotoxic response induced against a pathogen or a tumor antigen.
Background
The advantage to use the two types of dye (CFSE and BV) is for their high stability in vivo, both dyes could be detectable even more than one week in vivo (based on our lab experience), on the other hand, as we used Galios cytometer, CFSE and BV are read respectively in fl1 vs. fl9 (fl1 and fl9 are two different lasers used by the FACS machine) which is very practical for the settings and compensations.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2018 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Benkhoucha, M., Molnarfi, N., Belnoue, E., Derouazi, M. and Lalive, P. H. (2018). In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay. Bio-protocol 8(22): e3082. DOI: 10.21769/BioProtoc.3082.
分类
细胞生物学 > 基于细胞的分析方法 > 流式细胞术
癌症生物学 > 肿瘤免疫学 > 动物模型
免疫学 > 动物模型 > 小鼠
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link